Two faces of drug repurposing data in machine learning-driven structure-based virtual screening supported by interaction fingerprints

Krüger DM, Evers A (2010) Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors. ChemMedChem 5(1):148–158. https://doi.org/10.1002/cmdc.200900314

Article  CAS  PubMed  Google Scholar 

Li Z, Huang R, Xia M, Patterson TA, Hong H (2024) Fingerprinting interactions between proteins and ligands for facilitating machine learning in drug discovery. Biomolecules 14(1):72. https://doi.org/10.3390/biom14010072

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimber TB, Chen Y, Volkamer A, Kimber TB, Chen Y, Volkamer A (2021) Deep learning in virtual screening: recent applications and developments. Int J Mol Sci. https://doi.org/10.3390/ijms22094435

Article  PubMed  PubMed Central  Google Scholar 

Jiménez-Rosés M, Morgan BA, Jimenez Sigstad M, Tran TDZ, Srivastava R, Bunsuz A, Borrega‐Román L, Hompluem P, Cullum SA, Harwood CR, Koers EJ, Sykes DA, Styles IB, Veprintsev DB (2022) Combined Docking and Machine Learning Identify Key Molecular Determinants of Ligand Pharmacological Activity on Β2 adrenoceptor. Pharmacol Res Perspect 10(5):e00994. https://doi.org/10.1002/prp2.994

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szulc NA, Mackiewicz Z, Bujnicki JM, Stefaniak F (2023) Structural interaction fingerprints and machine learning for predicting and explaining binding of small molecule ligands to RNA. Brief Bioinform 24(4):bbad187. https://doi.org/10.1093/bib/bbad187

Article  CAS  PubMed  Google Scholar 

Gao K, Nguyen DD, Sresht V, Mathiowetz AM, Tu M, Wei G-W (2020) Are 2D fingerprints still valuable for drug discovery? Phys Chem Chem Phys 22(16):8373–8390. https://doi.org/10.1039/D0CP00305K

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng Z, Chuaqui C, Singh J (2004) Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein–ligand binding interactions. J Med Chem 47(2):337–344. https://doi.org/10.1021/jm030331x

Article  CAS  PubMed  Google Scholar 

Marcou G, Rognan D (2007) Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J Chem Inf Model 47(1):195–207. https://doi.org/10.1021/ci600342e

Article  CAS  PubMed  Google Scholar 

Pérez-Nueno VI, Rabal O, Borrell JI, Teixidó J (2009) APIF: A new interaction fingerprint based on atom pairs and its application to virtual screening. J Chem Inf Model 49(5):1245–1260. https://doi.org/10.1021/ci900043r

Article  CAS  PubMed  Google Scholar 

Wójcikowski M, Kukiełka M, Stepniewska-Dziubinska MM, Siedlecki P (2019) Development of a protein–ligand extended connectivity (PLEC) fingerprint and its application for binding affinity predictions. Bioinformatics 35(8):1334–1341. https://doi.org/10.1093/bioinformatics/bty757

Article  CAS  PubMed  PubMed Central  Google Scholar 

Da C, Kireev D (2014) Structural protein–ligand interaction fingerprints (SPLIF) for structure-based virtual screening: method and benchmark study. J Chem Inf Model 54(9):2555–2561. https://doi.org/10.1021/ci500319f

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gainza P, Wehrle S, Van Hall-Beauvais A, Marchand A, Scheck A, Harteveld Z, Buckley S, Ni D, Tan S, Sverrisson F, Goverde C, Turelli P, Raclot C, Teslenko A, Pacesa M, Rosset S, Georgeon S, Marsden J, Petruzzella A, Liu K, Xu Z, Chai Y, Han P, Gao GF, Oricchio E, Fierz B, Trono D, Stahlberg H, Bronstein M, Correia BE (2023) De novo design of protein interactions with learned surface fingerprints. Nature 617(7959):176–184. https://doi.org/10.1038/s41586-023-05993-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fellinger C, Seidel T, Merget B, Schleifer K-J, Langer T (2025) GRADE and X-GRADE:Unveiling novel protein–ligand interaction fingerprints based on GRAIL scores. J Chem Inf Model 65(5):2456–2475. https://doi.org/10.1021/acs.jcim.4c01902

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gossen J, Albani S, Hanke A, Joseph BP, Bergh C, Kuzikov M, Costanzi E, Manelfi C, Storici P, Gribbon P, Beccari AR, Talarico C, Spyrakis F, Lindahl E, Zaliani A, Carloni P, Wade RC, Musiani F, Kokh DB, Rossetti GA (2021) Blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics. ACS Pharmacol Transl Sci 4(3):1079–1095. https://doi.org/10.1021/acsptsci.0c00215

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schake P, Dishnica K, Kaiser F, Leberecht C, Haupt VJ, Schroeder M (2023) An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds. Sci Rep 13(1):9204. https://doi.org/10.1038/s41598-023-35671-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan A, Li W, Zhao X, Cao R, Li H, Chen L, Li X (2024) NoncovalentSARS-COV-2 main protease inhibitors: a virtual screening and molecular dynamic simulation study. Results Chem 7:101428. https://doi.org/10.1016/j.rechem.2024.101428

Article  CAS  Google Scholar 

Radifar M, Yuniarti N, Istyastono EP (2013) PyPLIF: python-based protein-ligand interaction fingerprinting. Bioinformation 9(6):325–328. https://doi.org/10.6026/97320630009325

Article  PubMed  PubMed Central  Google Scholar 

Jubb HC, Higueruelo AP, Ochoa-Montaño B, Pitt WR, Ascher DB, Blundell TL (2017) Arpeggio:A web server for calculating and visualising interatomic interactions in protein structures. J Mol Biol 429(3):365–371. https://doi.org/10.1016/j.jmb.2016.12.004

Article  CAS  PubMed  Google Scholar 

Duan Y, Wang H, Yuan Z, Yang H (2023) Structural biology of SARS-CoV-2 Mpro and drug discovery. Curr Opin Struct Biol 82:102667. https://doi.org/10.1016/j.sbi.2023.102667

Article  CAS  PubMed  Google Scholar 

Zakharova MY, Kuznetsova AA, Uvarova VI, Fomina AD, Kozlovskaya LI, Kaliberda EN, Kurbatskaia IN, Smirnov IV, Bulygin AA, Knorre VD, Fedorova OS, Varnek A, Osolodkin DI, Ishmukhametov AA, Egorov AM, Gabibov AG, Kuznetsov NA (2021) Pre-steady-state kinetics of the SARS-CoV-2 main protease as a powerful tool for antiviral drug discovery. Front Pharmacol 12:773198. https://doi.org/10.3389/fphar.2021.773198

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fomina AD, Uvarova VI, Kozlovskaya LI, Palyulin VA, Osolodkin DI, Ishmukhametov AA (2024) Ensemble docking based virtual screening of SARS-CoV‐2 main protease inhibitors. Mol Inf 43(8):e202300279. https://doi.org/10.1002/minf.202300279

Article  CAS  Google Scholar 

Macip G, Garcia-Segura P, Mestres-Truyol J, Saldivar-Espinoza B, Pujadas G, Garcia-Vallve S (2021) A review of the current landscape of SARS-CoV-2 main protease inhibitors: have we hit the bullseye yet? Int J Mol Sci 23(1):259. https://doi.org/10.3390/ijms23010259

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boby ML et al (2023) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science. https://doi.org/10.1126/science.abo7201

Article  PubMed  PubMed Central  Google Scholar 

Martin H-J, Melo-Filho CC, Korn D, Eastman RT, Rai G, Simeonov A, Zakharov AV, Muratov E, Tropsha A (2023) Small molecule antiviral compound collection (SMACC): a comprehensive, highly curated database to support the discovery of broad-spectrum antiviral drug molecules. Antiviral Res 217:105620. https://doi.org/10.1016/j.antiviral.2023.105620

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sterling T, Irwin JJ (2015) ZINC 15-ligand discovery for everyone. J Chem Inf Model 55(11):2324–2337. https://doi.org/10.1021/acs.jcim.5b00559

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fomina AD, Palyulin VA, Osolodkin DI (2024) Ho

Comments (0)

No login
gif